Prazitone

Prazitone
Clinical data
Other names	5-phenyl-5-(2-piperidylmethyl)barbituric acid
ATC code	none;
Identifiers
	IUPAC name 5-phenyl-5-(piperidin-2-ylmethyl)pyrimidine-2,4,6(1H,3H,5H)-trione;
CAS Number	2409-26-9 ;
PubChem CID	3050417;
ChemSpider	2312482 ;
UNII	6DZB018428;
Chemical and physical data
Formula	C16H19N3O3
Molar mass	301.346 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CCNC(C1)CC2(C(=O)NC(=O)NC2=O)C3=CC=CC=C3;
	InChI InChI=1S/C16H19N3O3/c20-13-16(11-6-2-1-3-7-11,14(21)19-15(22)18-13)10-12-8-4-5-9-17-12/h1-3,6-7,12,17H,4-5,8-10H2,(H2,18,19,20,21,22) ; Key:UGZAKKMLMJITLL-UHFFFAOYSA-N ;
	(what is this?) (verify)

Prazitone (AGN-511) is a barbiturate derivative developed in the 1970s.^[1] Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant.^[2] The dosage range in humans is around 200–600 mg, although higher doses have been used in trials for the treatment of depression associated with Parkinson's disease.

References edit

^ DE Patent 1645911
^ Ross Langlands. Method for imparting anti-depressant and/or anxiolytic effects to animals. US Patent 3,806,596

This article about an anxiolytic is a stub. You can help Wikipedia by expanding it.

[1] DE Patent 1645911

[2] Ross Langlands. Method for imparting anti-depressant and/or anxiolytic effects to animals. US Patent 3,806,596

[1]

[2]